Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Clinical Study with Patisiran

Next Previous
Trial Profile

A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Clinical Study with Patisiran

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Patisiran (Primary)
  • Indications Familial amyloid neuropathy
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms APOLLO-OLE
  • Sponsors Alnylam Pharmaceuticals

Most Recent Events

  • 01 Sep 2024 Results (n=14) the sub analysis examining the efficacy and safety of patisiran, in Taiwanese patients with hereditary transthyretin-mediated (hATTR) amyloidosis with polyneuropathy were published in the Journal of the Formosan Medical Association.
  • 15 Sep 2022 Status changed from active, no longer recruiting to completed.
  • 13 Sep 2022 Planned End Date changed from 1 Aug 2022 to 31 Dec 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top